Gorgisyan Jenny, Perrin Rosalind, Lomax Antony J, Persson Gitte F, Josipovic Mirjana, Engelholm Svend Aage, Weber Damien C, Munck Af Rosenschold Per
a Paul Scherrer Institute , Villigen PSI , Switzerland.
b Department of Oncology , Copenhagen University Hospital Rigshospitalet , Copenhagen , Denmark.
Acta Oncol. 2017 Jun;56(6):853-859. doi: 10.1080/0284186X.2017.1287950. Epub 2017 Feb 22.
The breath-hold technique inter alia has been suggested to mitigate the detrimental effect of motion on pencil beam scanned (PBS) proton therapy dose distributions. The aim of this study was to evaluate the robustness of incident proton beam angles to day-to-day anatomical variations in breath-hold.
Single field PBS plans at five degrees increments in the transversal plane were made and water-equivalent path lengths (WEPLs) were derived on the planning breath-hold CT (BHCT) for 30 patients diagnosed with locally-advanced non-small cell lung cancer (NSCLC), early stage NSCLC or lung metastasis. Our treatment planning system was subsequently used to recalculate the plans and derive WEPL on a BHCT scan acquired at the end of the treatment. Changes to the V, D and mean target dose were evaluated.
The difference in WEPL as a function of the beam angle was highly patient specific, with a median of 3.3 mm (range: 0.0-41.1 mm). Slightly larger WEPL differences were located around the lateral or lateral anterior/posterior beam angles. Linear models revealed that changes in dose were associated to the changes in WEPL and the tumor baseline shift (p < 0.05).
WEPL changes and tumor baseline shift can serve as reasonable surrogates for dosimetric uncertainty of the target coverage and are well-suited for routine evaluation of plan robustness. The two lateral beam angles are not recommended to use for PBS proton therapy of lung cancer patients treated in breath-hold, due to the poor robustness for several of the patients evaluated.
屏气技术尤其被认为可以减轻运动对笔形束扫描(PBS)质子治疗剂量分布的不利影响。本研究的目的是评估入射质子束角度对屏气时日常解剖学变化的稳健性。
为30例诊断为局部晚期非小细胞肺癌(NSCLC)、早期NSCLC或肺转移的患者,在横断面以5度增量制作单野PBS计划,并在计划屏气CT(BHCT)上得出水等效路径长度(WEPL)。随后使用我们的治疗计划系统重新计算计划,并在治疗结束时获取的BHCT扫描上得出WEPL。评估V、D和平均靶区剂量的变化。
作为束角函数的WEPL差异具有高度的患者特异性,中位数为3.3毫米(范围:0.0 - 41.1毫米)。在外侧或外侧前/后束角附近的WEPL差异略大。线性模型显示,剂量变化与WEPL变化和肿瘤基线移位相关(p < 0.05)。
WEPL变化和肿瘤基线移位可作为靶区覆盖剂量不确定性的合理替代指标,非常适合用于计划稳健性的常规评估。对于屏气治疗的肺癌患者,不建议使用两个外侧束角进行PBS质子治疗,因为在所评估的部分患者中稳健性较差。